Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04577313 · ClinicalTrials.gov registry record · NA

HIV Treatment Adherence Dose Determination Trial

A NA study of HIV Infections, sponsored by University of Connecticut.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
2
Study locations

NCT04577313 is a NA study of HIV Infections that is actively recruiting participants, run by University of Connecticut. The registered enrollment target is 400 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (10% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04577313, a NA study of HIV Infections, is actively recruiting participants, sponsored by University of Connecticut.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
2
Study locations

Study Summary

The proposed research will conduct the first dose-determination trial to find the optimal number of behavioral counseling sessions (dose) needed to achieve and sustain optimal HIV treatment adherence. The results of this study will determine how much intervention is needed for whom and at what cost to guide health policy and implementation of behavioral interventions designed to improve durable viral suppression.

Conditions Studied

HIV Infections

Interventions

  • BEHAVIORAL Behavioral Self-Regulation Adherence Counseling

Study Locations (2)

Connecticut

  • University of Connecticut - Storrs

Georgia

  • University of Connecticut Field Site - Atlanta

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2020-09-01
Est. Completion 2026-11-30
Phase NA

Sponsor

University of Connecticut

107 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04577313

The ClinicalTrials.gov registry entry for NCT04577313 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (10% lower). The listed sponsor is University of Connecticut, which has 107 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Behavioral Self-Regulation Adherence Counseling is the first listed.

NCT04577313 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, Georgia.

Frequently Asked Questions

What is clinical trial NCT04577313 about?

NCT04577313 is a clinical study titled "HIV Treatment Adherence Dose Determination Trial". The proposed research will conduct the first dose-determination trial to find the optimal number of behavioral counseling sessions (dose) needed to achieve and sustain optimal HIV treatment adherence. The results of this study will determine how much intervention is needed for whom and at what cost ...

What is the current status of trial NCT04577313?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2020-09-01. Estimated completion is 2026-11-30.

What conditions does trial NCT04577313 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT04577313?

The interventions under investigation include: Behavioral Self-Regulation Adherence Counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT04577313?

This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04577313 being conducted?

This trial has 2 study locations across Connecticut, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.